Replicel Life Sciences Stock Beneish M Score

RP Stock  CAD 0.01  0.00  0.00%   
This module uses fundamental data of RepliCel Life to approximate the value of its Beneish M Score. RepliCel Life M Score tells investors if the company management is likely to be manipulating earnings. The score is calculated using eight financial indicators that are adjusted by a specific multiplier. Please note, the M Score is a probabilistic model and cannot detect companies that manipulate their earnings with 100% accuracy. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in RepliCel Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
  
At this time, RepliCel Life's Net Debt is fairly stable compared to the past year. Short Term Debt is likely to climb to about 853.8 K in 2024, whereas Long Term Debt is likely to drop slightly above 38.1 K in 2024. At this time, RepliCel Life's Invested Capital is fairly stable compared to the past year. Stock Based Compensation To Revenue is likely to climb to 0.72 in 2024, despite the fact that PTB Ratio is likely to grow to (0.81).
At this time, RepliCel Life's M Score is inapplicable. The earnings manipulation may begin if RepliCel Life's top management creates an artificial sense of financial success, forcing the stock price to be traded at a high price-earnings multiple than it should be. In general, excessive earnings management by RepliCel Life executives may lead to removing some of the operating profits from subsequent periods to inflate earnings in the following periods. This way, the manipulation of RepliCel Life's earnings can lead to misrepresentations of actual financial condition, taking the otherwise loyal stakeholders on to the path of questionable ethical practices and plain fraud.
-2.45
Beneish M Score - Inapplicable
Elasticity of Receivables

0.75

Focus
Asset Quality

0.91

Focus
Expense Coverage

0.92

Focus
Gross Margin Strengs

N/A

Focus
Accruals Factor

0.92

Focus
Depreciation Resistance

1.0

Focus
Net Sales Growth

1.37

Focus
Financial Leverage Condition

1.11

Focus

RepliCel Life Beneish M-Score Indicator Trends

The cure to earnings manipulation is the transparency of financial reporting. It will typically remove the temptation of the top executives to inflate earnings (i.e., to promote the idea of 'winning at any cost'). Because a healthy internal audit department can enhance transparency, the board should promote the auditors' access to all the record-keeping systems across the enterprise. For example, if RepliCel Life's auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back.
Current ValueLast YearChange From Last Year 10 Year Trend
Net Receivables39 K38 K
Fairly Up
Slightly volatile
Total Assets273.4 K287.8 K
Notably Down
Pretty Stable
Total Current Assets154 K162.1 K
Notably Down
Pretty Stable
Non Current Assets Total119.4 K125.7 K
Notably Down
Slightly volatile
Property Plant Equipment2.8 K2.9 K
Notably Down
Slightly volatile
Depreciation And Amortization1.4 K1.5 K
Notably Down
Slightly volatile
Selling General Administrative1.5 M1.2 M
Significantly Up
Slightly volatile
Total Current Liabilities1.9 M1.8 M
Sufficiently Up
Slightly volatile
Long Term Debt38.1 K47.1 K
Significantly Down
Slightly volatile
Long Term Investments950.5 K973.1 K
Fairly Down
Slightly volatile

RepliCel Life Sciences Beneish M-Score Driver Matrix

One of the toughest challenges investors face today is learning how to quickly synthesize historical financial statements and information provided by the company, SEC reporting, and various external parties in order to detect the potential manipulation of earnings. Understanding the correlation between RepliCel Life's different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards RepliCel Life in a much-optimized way. Analyzing correlations between earnings drivers directly associated with dollar figures is the most effective way to find RepliCel Life's degree of accounting gimmicks and manipulations.

About RepliCel Life Beneish M Score

M-Score is one of many grading techniques for value stocks. It was developed by Professor M. Daniel Beneish of the Kelley School of Business at Indiana University and published in 1999 under the paper titled The Detection of Earnings Manipulation. The Beneish score is a multi-factor model that utilizes financial identifiers to compile eight variables used to classify whether a company has manipulated its reported earnings. The variables are built from the officially filed financial statements to create a final score call 'M Score.' The score helps to identify companies that are likely to manipulate their profits if they show deteriorating gross margins, operating expenses, and leverage against growing revenue.

Depreciation And Amortization

1,397.45

At this time, RepliCel Life's Depreciation And Amortization is fairly stable compared to the past year.

RepliCel Life Earnings Manipulation Drivers

Although earnings manipulation is typically not the result of intentional misconduct by the c-level executives, it is still a widespread practice by the senior management of public companies such as RepliCel Life. It is usually done by a series of misrepresentations of various accounting rules and operating activities across multiple financial cycles. The best way to spot the manipulation is to examine the historical financial statement to find inconsistencies in earning reports to find trends in assets or liabilities that are not sustainable in the future.
201920202021202220232024 (projected)
Net Receivables51.9K63.6K61.2K82.2K38.0K39.0K
Total Assets505.5K421.0K591.8K798.2K287.8K273.4K
Total Current Assets233.2K185.7K393.0K635.7K162.1K154.0K
Net Debt425.4K41.7K(186.9K)(372.1K)754.0K791.7K
Short Term Debt449.3K47.3K611.4K689.3K813.2K853.8K
Operating Income(2.9M)(1.1M)(3.2M)(191.4K)(1.4M)(1.5M)

About RepliCel Life Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze RepliCel Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of RepliCel Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of RepliCel Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for RepliCel Stock Analysis

When running RepliCel Life's price analysis, check to measure RepliCel Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RepliCel Life is operating at the current time. Most of RepliCel Life's value examination focuses on studying past and present price action to predict the probability of RepliCel Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RepliCel Life's price. Additionally, you may evaluate how the addition of RepliCel Life to your portfolios can decrease your overall portfolio volatility.